Max Lerchenberger
Impact in
-
- Cell Adhesion Molecules Research
-
- Neutrophil, Myeloperoxidase and Oxidative Mechanisms
- Immune Response and Inflammation
Papers in
-
- Cell Adhesion Molecules Research 2
-
- Trauma, Hemostasis, Coagulopathy, Resuscitation 1
- Co-authors
- Christoph A. ReichelMarkus RehbergPéter BihariFritz KrombachStefan ZahlerMarc PraetnerAlexander G. KhandogaBernd Uhl
- Journals
- Biomaterials (1 paper)Arteriosclerosis Thrombosis and Vascular Biology (1 paper)Circulation (1 paper)Toxicology (1 paper)PLoS ONE (1 paper)
- Partner nations
- GermanySlovakiaSwitzerland
In The Last Decade
Max Lerchenberger
7 papers receiving 409 citations
Peers
Comparison fields: 5 of 75
- Immunology and Allergy 34
- Immunology 93
- Hematology 39
- Nephrology 24
- Biomaterials 43
Countries citing papers authored by Max Lerchenberger
This map shows the geographic impact of Max Lerchenberger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Max Lerchenberger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Max Lerchenberger more than expected).
Fields of papers citing papers by Max Lerchenberger
This network shows the impact of papers produced by Max Lerchenberger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Max Lerchenberger. The network helps show where Max Lerchenberger may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Max Lerchenberger, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 30 | |
| 2 | 2013 | 36 | |
| 3 | 2011 | 60 | |
| 4 | 2011 | 34 | |
| 5 | 2010 | 40 | |
| 6 | 2009 | 106 | |
| 7 | 2009 | 108 |
About Max Lerchenberger
Max Lerchenberger is a scholar working on Immunology and Allergy, Critical Care and Intensive Care Medicine, Biochemistry, Nephrology and Neurology, having authored 7 papers that have together received 414 indexed citations. Recurring topics across this work include Cell Adhesion Molecules Research (2 papers), Nanoparticle-Based Drug Delivery (1 paper), Sympathectomy and Hyperhidrosis Treatments (1 paper), Quantum Dots Synthesis And Properties (1 paper), Trauma, Hemostasis, Coagulopathy, Resuscitation (1 paper), Platelet Disorders and Treatments (1 paper), Immune Response and Inflammation (1 paper) and Acute Ischemic Stroke Management (1 paper). The work is most often cited by research in Immunology and Allergy (34 citations), Immunology (93 citations), Hematology (39 citations), Nephrology (24 citations) and Biomaterials (43 citations). Max Lerchenberger has collaborated with scholars based in Germany, Slovakia and Switzerland. Frequent co-authors include Christoph A. Reichel, Markus Rehberg, Péter Bihari, Fritz Krombach, Stefan Zahler, Marc Praetner, Alexander G. Khandoga, Bernd Uhl, Martin Holzer and Fritz Krombach. Their work appears in journals such as Biomaterials, Arteriosclerosis Thrombosis and Vascular Biology, Circulation, Toxicology and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.